NYSE:MDTMedical Equipment
Should Medtronic’s (MDT) New AI Surgical and Cardiac Approvals Prompt a Fresh Look from Investors?
In late March 2026, Medtronic reported a series of U.S. FDA clearances and approvals across cardiac and surgical devices, including the AI-enabled Stealth AXiS surgical system for cranial and ENT procedures and an expanded indication for its OmniaSecure defibrillation lead, alongside a new U.S. distribution agreement for Merit Medical’s ViaVerte basivertebral nerve ablation system.
Together, these moves highlight Medtronic’s push toward integrated, AI-supported platforms and broader therapy...